# Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes Mellitus

> **NCT04232293** · NA · COMPLETED · sponsor: **Nantes University Hospital** · enrollment: 722 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2
- NAFLD
- NASH

## Interventions

- **DIAGNOSTIC_TEST:** Blood tests

## Key facts

- **NCT ID:** NCT04232293
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-25
- **Primary completion:** 2025-06-27
- **Final completion:** 2025-06-27
- **Target enrollment:** 722 (ACTUAL)
- **Last updated:** 2025-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04232293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04232293, "Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04232293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*